IndiaOne Finance - Company Dashboard

Governance Classic Home

Bal Pharma LtdPharmaceuticalsINE083D01012Consolidated₹100.67-1.79 (-1.75%)Jun-26

Valuation

Market Cap₹160.28 Cr

TTM PE22.17x

Forward PE18.46x

PEG1.51

Book Value₹51.65

P/B1.95x

TTM EPS₹4.54

Fwd EPS₹5.45

TTM Revenue₹334.42 Cr

TTM PAT₹7.25 Cr

TTM EBITDA₹33.81 Cr

TTM EBIT₹22.47 Cr

Last Qtr PAT₹1.14 Cr

Last Qtr EBITDA₹7.95 Cr

Last Qtr EBIT₹5.17 Cr

Profitability

ROE8.82%

ROCE9.97%

TTM NPM2.17%

TTM EBITDA %10.11%

Curr OPM1.28%

Last OPM4.29%

Curr NPM—

Last NPM—

Curr EPS₹0.71

Last EPS₹2.26

Balance sheet

Equity₹15.92 Cr

Reserve₹66.31 Cr

Total Debt₹159.51 Cr

D/E1.94x

Interest %392.11%

Curr Interest₹4.47 Cr

Price / range

Close₹100.67

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-1.75%

1W-6.28%

1M+18.03%

3M+14.67%

6M+46.11%

1Y+19.16%

2Y-23.62%

3Y+5.78%

5Y-3.57%

Diwali+36.80%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	88.43+34.7%	83.92	87.50	73.75	65.64	310.80
Other Income	0.46	-0.22	0.35	1.14	0.74	2
Total Income	88.88+33.9%	83.70	87.84	74.88	66.38	312.80
Interest	4.47	4.05	4.85	3.86	4.05	16.81
Expenditure	-87.72-32.8%	-80.39	-85.89	-74.10	-66.05	-306.43
PBDT	0	0	0	0	0	0
EBITDA	7.96+29.2%	10.62	9.69	5.78	6.16	32.24
Depreciation	-2.78	-3.04	-3.23	-2.27	-2.52	-11.06
EBIT	5.18+42.3%	7.58	6.46	3.51	3.64	21.18
PBT	1.16+262.5%	3.31	1.95	0.78	0.32	6.37
Tax	0	0.39	0	0	0	0.39
Equity	15.92	15.92	0	0	15.92	15.92
OPM	1.31	3.95	2.22	1.06	0.48	2.03
Net Profit	1.16+262.5%	3.70	1.95	0.78	0.32	6.75
NPM	1.31	4.42	2.22	1.06	0.48	2.16
EPS	0.73+265.0%	2.60	1.22	0.49	0.20	4.27

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	310.80+2.7%	302.50-10.6%	338.54+11.7%	303.10+8.1%	280.37+12.5%	249.31
Other Income	2	2.15	3.35	2.16	6.49	2.70
Total Income	312.80+2.7%	304.65-10.9%	341.89+12.0%	305.25+6.4%	286.86+13.8%	252.01
Expenditure	-306.43-2.5%	-298.91+9.4%	-329.79-11.2%	-296.70-8.0%	-274.80-13.5%	-242.21
Interest	-16.81	-16.85	-15.24	-12.16	-10.40	-11.96
PBDT	0	0	0	0	0	0
EBITDA	32.24+7.1%	30.09-7.2%	32.44+24.6%	26.04+12.2%	23.21-11.8%	26.32
Depreciation	-11.06	-9.65	-8.45	-7.48	-7.24	-7.26
EBIT	21.18+3.6%	20.44-14.8%	23.99+29.3%	18.56+16.2%	15.97-16.2%	19.06
PBT	6.37+11.2%	5.73-52.7%	12.11+41.6%	8.55-29.1%	12.06+23.1%	9.80
Tax	0.39	2.07	-1.83	-2.42	-3.48	-0.70
Equity	15.92	15.92	0	0	0	0
OPM (%)	2.03	1.88	4.00	3.00	4.00	4.00
Net Profit	6.75-13.5%	7.80-24.1%	10.27+67.5%	6.13-28.6%	8.58-5.7%	9.10
NPM (%)	2.16	2.56	3.00	2.00	3.00	4.00
EPS (Rs)	4.27-12.7%	4.89-27.2%	6.72+72.3%	3.90-32.6%	5.79-9.7%	6.41
CEPS	4.27	4.89	6.75	3.94	5.67	6.41

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	88.62+34.5%	84.08	87.69	74.03	65.87	311.66
Other Income	0.44	-0.24	0.33	1.12	0.72	1.93
Total Income	89.05+33.7%	83.84	88.02	75.14	66.59	313.59
Interest	4.47	4.06	4.85	3.86	4.05	16.82
Expenditure	-87.92-32.4%	-80.62	-86.23	-74.42	-66.38	-307.65
PBDT	0	0	0	0	0	0
EBITDA	7.95+31.2%	10.58	9.54	5.74	6.06	31.91
Depreciation	-2.78	-3.06	-3.23	-2.27	-2.52	-11.08
EBIT	5.17+46.0%	7.52	6.31	3.47	3.54	20.83
PBT	1.14+442.9%	3.22	1.79	0.72	0.21	5.94
Tax	0	0.39	0	0	0	0.39
Equity	15.92	15.92	0	0	15.92	15.92
OPM	1.28	3.84	2.03	0.95	0.32	1.89
Net Profit	1.14+442.9%	3.60	1.79	0.72	0.21	6.32
NPM	1.28	4.29	2.03	0.95	0.32	2.02
EPS	0.71+446.2%	2.26	1.12	0.45	0.13	3.95

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	311.66+2.8%	303.08-10.7%	339.22+11.5%	304.22+8.2%	281.22+12.3%	250.53
Other Income	1.93	2.20	2.85	0.94	5.15	1.14
Total Income	313.59+2.7%	305.29-10.8%	342.07+12.1%	305.16+6.6%	286.37+13.8%	251.67
Expenditure	-307.65-2.5%	-300.15+9.9%	-333.02-10.9%	-300.41-8.4%	-277.18-12.0%	-247.56
Interest	-16.82	-16.85	-15.26	-12.19	-10.41	-11.97
PBDT	0	0	0	0	0	0
EBITDA	31.91+8.0%	29.55-6.3%	31.53+25.5%	25.13+7.0%	23.49-4.0%	24.46
Depreciation	-11.08	-9.77	-10.07	-9.13	-9.04	-9.52
EBIT	20.83+5.3%	19.78-7.8%	21.46+34.1%	16+10.7%	14.45-3.3%	14.94
PBT	5.94+15.6%	5.14-43.2%	9.05+90.5%	4.75-48.3%	9.18+123.9%	4.10
Tax	0.39	2.10	-1.60	-2.13	-3.48	0.61
Equity	15.92	15.92	0	0	0	0
OPM (%)	1.89	1.68	2.64	1.56	3.21	1.63
Net Profit	6.32-12.2%	7.20-3.4%	7.45+184.4%	2.62-54.1%	5.71+21.2%	4.71
NPM (%)	2.02	2.36	2.18	0.86	1.99	1.87
EPS (Rs)	3.95-13.4%	4.56-7.7%	4.94+195.8%	1.67-55.9%	3.79+13.5%	3.34
CEPS	3.95	4.56	4.96	1.68	3.71	3.34

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	1.2	18 Sep 2025
2024	Final Dividend	1.2	18 Sep 2024
2024	Final Dividend	1.2	17 Sep 2024
2023	Final Dividend	1	18 Sep 2023
2022	Final Dividend	1	13 Sep 2022
2021	Final Dividend	1	16 Sep 2021
2019	Final Dividend	1	17 Sep 2019
2018	Final Dividend	1	14 Sep 2018
2017	Final Dividend	1	14 Sep 2017
2016	Final Dividend	1	15 Sep 2016
2015	Final Dividend	1	15 Sep 2015
2014	Final Dividend	1	12 Sep 2014
2013	Final Dividend	0.75	12 Sep 2013
2009	Final Dividend	0.75	17 Sep 2009
2008	Final Dividend	1	09 Sep 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split